Boston Scientific says suspends Watchman FLX sales in Europe

(Reuters) - Boston Scientific Corp on Monday said it has temporarily stopped selling a newer version of its Watchman atrial fibrillation treatment in Europe due to a higher-than-expected rate of embolisms associated with the implant.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro